Stock Events

Stock Events

Search...

Biosenic

€0.02

19

+€0+5.56% Friday 17:35

Statistics

Day High

0.02

Day Low

0.02

52W High

-

52W Low

-

Volume

1,721,638

Avg. Volume

-

Mkt Cap

-

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIOS.PA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Biosenic's offerings.

Thermo Fisher Scientific

Thermo Fisher Scientific offers a broad range of biotechnology products, including genomics and proteomics tools, which overlap with Biosenic's market.

Qiagen is known for sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics and research market.

Bio-Rad Laboratories

Bio-Rad Laboratories manufactures and supplies products and systems used for gene expression, protein purification, and analysis, which are areas Biosenic may also operate in.

Pacific Biosciences of California

Pacific Biosciences offers long-read sequencing technologies, which can be seen as complementary or competitive to Biosenic's offerings depending on their focus in genomics.

Agenus is involved in immuno-oncology, a field that may overlap with Biosenic's work if they are involved in developing therapies or diagnostics based on genetic information.

Guardant Health

Guardant Health focuses on liquid biopsies and cancer diagnostics through genomic sequencing, competing in the precision medicine space.

Intellia Therapeutics

Intellia Therapeutics is a leading genome editing company, which could be a competitor if Biosenic is involved in therapeutic applications of genomics.

CRISPR Therapeutics

CRISPR Therapeutics is focused on developing gene-based medicines, potentially competing with Biosenic if they are involved in therapeutic genomics.

About

Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.

Show more...

CEO

Dr. Miguel Forte M.D., Ph.D.

Employees

20

Country

BE

ISIN

BE0974280126

Listings